secwatch.observer — SEC 8-K summary
======================================

Issuer:     P3 Health Partners Inc. (PIII)
CIK:        0001832511
Form:       8-K
Filed at:   2026-08-10T20:03:10+00:00
Accession:  0001832511-26-000032
Event type: earnings
Sentiment:  positive
Materiality: 0.80
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

P3 Health Partners Q2 2026: Net income $15.7M vs loss, raises FY adjusted EBITDA guidance to $80-110M
--------------------------------------------------------------------------------

- Q2 revenue $386M, +9% YoY; net income $15.7M vs net loss $43.7M prior-year quarter.
- Adjusted EBITDA $54.4M ($173 PMPM) vs -$17.1M (-$49 PMPM) a year ago.
- At-risk membership ~105,000, down 10% YoY on intentional network/payer rationalization.
- Medical margin $97.8M ($311 PMPM); excluding payer settlements and prior-year development, $52.9M ($168 PMPM).
- Raised full-year 2026 adjusted EBITDA guidance to $80-110M; revenue guidance $1.5-1.6B.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1832511/000183251126000032/0001832511-26-000032-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1832511/000183251126000032/piii-20260810.htm
  HTML page:      https://secwatch.observer/filing/0001832511-26-000032

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer